Grossman; Iris

Patent Applications and Registrations

Patent applications and USPTO patent grants for Grossman; Iris.The latest application filed is for "methods of treating liver diseases".

Company Profile

4.4.19

Grossman; Iris - Cambridge MA
GROSSMAN; Iris - Rehovot IL
Grossman; Iris - Brookline MA
GROSSMAN; Iris - Yakir IL
Grossman; Iris - Haifa IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Treating Liver Diseases App 20220107328 - Bumcrot; David A. ; et al.	2022-04-07
Chimeric Quiescin Sulfhydryl Oxidase (qsox1) Antibodies And Uses Of Same App 20210292437 - FASS; Deborah ; et al.	2021-09-23
Antibodies Targeting Quiescin Sulfhydryl Oxidase (qsox1) And Uses Of Same App 20210147575 - FASS; Deborah ; et al.	2021-05-20
Identifying Therapeutic Targets by Discovering Interactions between Non-Coding Variants and Candidate Genes App 20210118524 - Liu; Yuting ; et al.	2021-04-22
Antibodies targeting quiescin sulfhydryl oxidase (QSOX1) and uses of same Grant 10,829,561 - Fass , et al. November 10, 2	2020-11-10
Antibodies Targeting Quiescin Sulfhydryl Oxidase (qsox1) And Uses Of Same App 20180273639 - FASS; Deborah ; et al.	2018-09-27
Genetic Markers Predictive Of Response To Glatiramer Acetate App 20180002753 - TCHELET; Amir ; et al.	2018-01-04
Compositions For Inhibition Of Quiescin Sulfhydryl Oxidase (qsox1) And Uses Of Same App 20170247468 - FASS; Deborah ; et al.	2017-08-31
Genetic markers predictive of response to glatiramer acetate Grant 9,702,007 - Tchelet , et al. July 11, 2	2017-07-11
Compositions for inhibition of quiescin sulfhydryl oxidase (QSOX1) and uses of same Grant 9,631,028 - Fass , et al. April 25, 2	2017-04-25
Biological Characterization Of A Glatiramer Acetate Related Drug Product Using Mammalian And Human Cells App 20170003277 - Hayden; Michael ; et al.	2017-01-05
Select Single Nucleotide Polymorphisms Predictive Of Response To Glatiramer Acetate App 20160312284 - Grossman; Iris ; et al.	2016-10-27
Determination Of Single Nucleotide Polymorphisms Useful To Predict Response For Rasagiline App 20150275302 - Masellis; Mario ; et al.	2015-10-01
Compositions For Inhibition Of Quiescin Sulfhydryl Oxidase (qsox1) And Uses Of Same App 20150110786 - Fass; Deborah ; et al.	2015-04-23
Genetic Markers Predictive Of Response To Glatiramer Acetate App 20150110733 - TCHELET; Amir ; et al.	2015-04-23
Markers associated with the therapeutic efficacy of glatiramer acetate App 20100285600 - Lancet; Doron ; et al.	2010-11-11
Markers associated with the therapeutic efficacy of glatiramer acetate App 20060240463 - Lancet; Doron ; et al.	2006-10-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.